Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | INPP5A | Q14642 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MLNR | O43193 | 1/20 | 0.34 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.34 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
| ▸ | FYN | P06241 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27722349 | 1.00 | FDPS (0.39) | FDPSKMT2AINPP5ACYP2D6MEN1 | |
| Sulfuric Acid SCHEMBL28199660 | 0.79 | FDPS (0.44) | FDPSKMT2ACYP2D6MEN1LMNA | |
| SCHEMBL1870883 | 0.78 | KMT2A (0.36) | FDPSKMT2ACYP2D6MEN1LMNA | |
| SCHEMBL20762013 | 0.78 | APLNR (0.36) | FDPSKMT2ACYP2D6MEN1LMNA | |
| SCHEMBL6393331 | 0.78 | KMT2A (0.36) | FDPSKMT2ACYP2D6MEN1LMNA | |
| SCHEMBL25040341 | 0.78 | APLNR (0.36) | FDPSKMT2ACYP2D6MEN1LMNA | |
| SCHEMBL4723842 | 0.78 | KMT2A (0.36) | FDPSKMT2ACYP2D6MEN1LMNA | |
| Hydrochloric Acid SCHEMBL20744622 | 0.77 | KMT2A (0.38) | FDPSKMT2ACYP2D6MEN1LMNA | |
| SCHEMBL1709329 | 0.74 | — | — | |
| SCHEMBL512365 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2578577-A1 | Sulfonyl esters of tetrahydrocannabinol and derivatives thereof | Albany Molecular Research, Inc. (US) | 2013-04-10 | — | — | EP | claimed |
| US-7674922-B2 | Process for production of delta-9-tetrahydrocannabinol | ALBANY MOLECULAR RESEARCH, INC. (US) | 2010-03-09 | — | — | US | claimed |
| EP-1928853-A2 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | AMR Technology, Inc. (US) | 2008-06-11 | — | — | EP | claimed |
| US-20070093665-A1 | Process for production of delta-9- tetrahydrocannabinol | AMR TECHNOLOGY, INC. (US) | 2007-04-26 | — | — | US | claimed |
| WO-2007041167-A2 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | AMR TECHNOLOGY, INC. (US) | 2007-04-12 | — | — | WO | claimed |
| EP-0467856-B1 | Aminoalkanesulfonic acid derivatives and pharmaceutical compositions for use in preventing or treating heart diseases | NIPPON ZOKI PHARMACEUTICAL CO (JP) | 1997-03-19 | — | — | EP | claimed |
| EP-0467856-A2 | Aminoalkanesulfonic acid derivatives and pharmaceutical compositions for use in preventing or treating heart diseases | NIPPON ZOKI PHARMACEUTICAL CO. LTD. (JP) | 1992-01-22 | — | — | EP | claimed |
| US-10265644-B2 | Enantioselective zwitterionic ion-exchange material | UNIVERSITAET WIEN (AT) | 2019-04-23 | — | — | US | disclosed |
| US-10265644-B2 | Enantioselective zwitterionic ion-exchange material | UNIVERSITAET WIEN (AT) | 2019-04-23 | — | — | US | disclosed |
| EP-2276567-B1 | ENANTIOSELECTIVE ZWITTERIONIC ION-EXCHANGE MATERIAL | UNIV WIEN (AT) | 2019-04-10 | — | — | EP | disclosed |
| US-20160193547-A1 | ENANTIOSELECTIVE ZWITTERIONIC ION-EXCHANGE MATERIAL | UNIVERSITAET WIEN (AT) | 2016-07-07 | — | — | US | disclosed |
| US-20160193547-A1 | ENANTIOSELECTIVE ZWITTERIONIC ION-EXCHANGE MATERIAL | UNIVERSITAET WIEN (AT) | 2016-07-07 | — | — | US | disclosed |
| US-20160193547-A1 | ENANTIOSELECTIVE ZWITTERIONIC ION-EXCHANGE MATERIAL | UNIVERSITAET WIEN (AT) | 2016-07-07 | — | — | US | disclosed |
| US-7244764-B2 | Methods and compositions for treating amyloid-related diseases | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2007-07-17 | — | — | US | disclosed |
| US-7244764-B2 | Methods and compositions for treating amyloid-related diseases | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2007-07-17 | — | — | US | disclosed |
| US-20070093665-A1 | Process for production of delta-9- tetrahydrocannabinol | AMR TECHNOLOGY, INC. (US) | 2007-04-26 | — | — | US | disclosed |
| WO-2007041167-A2 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | AMR TECHNOLOGY, INC. (US) | 2007-04-12 | — | — | WO | disclosed |
| EP-0467856-B1 | Aminoalkanesulfonic acid derivatives and pharmaceutical compositions for use in preventing or treating heart diseases | NIPPON ZOKI PHARMACEUTICAL CO (JP) | 1997-03-19 | — | — | EP | disclosed |
| US-5430052-A | Protective effect against myocardial disorders caused by calcium ion overload; antiischemic agents; remedy for heart failure, angina pectoris | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 1995-07-04 | — | — | US | disclosed |
| EP-0467856-A2 | Aminoalkanesulfonic acid derivatives and pharmaceutical compositions for use in preventing or treating heart diseases | NIPPON ZOKI PHARMACEUTICAL CO. LTD. (JP) | 1992-01-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070093665-A1 | Process for production of delta-9- tetrahydrocannabinol | CNR2, CNR1, HRH4 | FDPS 794/4885KMT2A 2043/4885INPP5A 3250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.